drugset / Trial / NCT05026125

Quality Assessment of Orotracheal Intubation Without Neuromuscular Blocking Agents in Obese Patients

NCT05026125 ↗

Phase 4 Completed 60 enrolled University Hospital, Toulouse
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will assess the condition of orotracheal intubation in obese patients undergoing an elective bariatric surgery without the use of neuromuscular blocking agents. During the induction of general anesthesia, Propofol - Remifentanil combination will be used. The patients will be randomized in 2 groups with different doses of Remifentanil.

Timeline

Start
2022-01-13
Primary completion
2023-08-11
Completion
2023-08-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Remifentanil Small molecule 3 ug/kg Other
Comparator Remifentanil Small molecule 3.9 ug/kg Other

Indications